Aurinia Pharmaceuticals (NASDAQ:AUPH) Rating Increased to Strong-Buy at StockNews.com
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) (TSE:AUP) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Thursday. Separately, Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price objective on shares of Aurinia Pharmaceuticals in a research […]
More Stories
Pentagon to Wind Back US Troop Footprint in Syria
By Ryan Morgan The Pentagon is preparing to downsize the U.S. military footprint in Syria in the coming weeks, citing...
UBS Group Lowers NVIDIA (NASDAQ:NVDA) Price Target to $180.00
NVIDIA (NASDAQ:NVDA – Get Free Report) had its target price cut by stock analysts at UBS Group from $185.00 to...
Cantor Fitzgerald Cuts Alphabet (NASDAQ:GOOGL) Price Target to $159.00
Alphabet (NASDAQ:GOOGL – Free Report) had its target price lowered by Cantor Fitzgerald from $200.00 to $159.00 in a report...
Wedbush Weighs in on Alphabet’s Q1 Earnings (NASDAQ:GOOGL)
Alphabet Inc. (NASDAQ:GOOGL – Free Report) – Investment analysts at Wedbush reduced their Q1 2025 earnings per share estimates for...
Bank of Montreal Can Acquires 2,830 Shares of OGE Energy Corp. (NYSE:OGE)
Bank of Montreal Can boosted its holdings in OGE Energy Corp. (NYSE:OGE – Free Report) by 10.7% during the fourth...
Cerity Partners LLC Has $981,000 Holdings in The Mosaic Company (NYSE:MOS)
Cerity Partners LLC trimmed its stake in The Mosaic Company (NYSE:MOS – Free Report) by 37.8% in the fourth quarter,...